Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Buy
2,040
+410
+25% +$48K 0.06% 112
2026
Q1
$196K Buy
+1,630
New +$188K 0.06% 116
2025
Q2
Sell
-2,351
Closed -$211K 173
2025
Q1
$211K Sell
2,351
-51
-2% -$4.76K 0.07% 106
2024
Q4
$239K Buy
2,402
+51
+2% +$5.26K 0.07% 100
2024
Q3
$267K Sell
2,351
-386
-14% -$45.9K 0.08% 98
2024
Q2
$339K Buy
2,737
+400
+17% +$51.5K 0.11% 87
2024
Q1
$308K Sell
2,337
-618
-21% -$76.2K 0.1% 94
2023
Q4
$322K Sell
2,955
-154
-5% -$16K 0.12% 89
2023
Q3
$320K Sell
3,109
-9
-0.3% -$970 0.13% 89
2023
Q2
$360K Sell
3,118
-351
-10% -$39.9K 0.14% 83
2023
Q1
$369K Buy
3,469
+206
+6% +$22.2K 0.15% 74
2022
Q4
$362K Sell
3,263
-964
-23% -$98.5K 0.16% 72
2022
Q3
$364K Sell
4,227
-29
-0.7% -$2.59K 0.17% 70
2022
Q2
$388K Sell
4,256
-521
-11% -$46.2K 0.17% 67
2022
Q1
$392K Hold
4,777
0.15% 79
2021
Q4
$366K Buy
4,777
+775
+19% +$61.7K 0.14% 80
2021
Q3
$301K Hold
4,002
0.13% 88
2021
Q2
$311K Sell
4,002
-192
-5% -$14.3K 0.13% 81
2021
Q1
$309K Hold
4,194
0.14% 77
2020
Q4
$327K Hold
4,194
0.17% 69
2020
Q3
$332K Sell
4,194
-25
-0.6% -$1.96K 0.21% 62
2020
Q2
$311K Buy
4,219
+870
+26% +$65.5K 0.22% 62
2020
Q1
$246K Sell
3,349
-165
-5% -$13K 0.23% 64
2019
Q4
$305K Buy
+3,514
New +$289K 0.22% 66

Other funds holding MRK

Ballast Advisors's MRK Position: Q2 2026 in Review

Ballast Advisors increased its Merck (MRK) stake by 25% in Q2 2026, buying an estimated $48K and bringing the position to 2,040 shares worth $262K. The position accounts for 0.06% of the portfolio, ranked #112.

Ballast Advisors first reported a position in MRK in Q4 2019 and has held it in 24 quarters since. The position peaked at $392K in Q1 2022. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ballast Advisors held 2,040 shares of Merck worth $262K as of Q2 2026.
  • Ballast Advisors bought 410 Merck shares in Q2 2026, an estimated $48K.
  • Merck made up 0.06% of Ballast Advisors's portfolio in Q2 2026, its #112 holding.
  • Ballast Advisors first reported a position in Merck in Q4 2019 and has held it in 24 quarters since.
  • Ballast Advisors's Merck position peaked at $392K in Q1 2022.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.